FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990032829> ?p ?o ?g. }

• W1990032829 endingPage "656" @default.
• W1990032829 startingPage "652" @default.
• W1990032829 abstract "Five peptide fragments, based on the C-terminal sequence of bombesin (BN)-(6-14) or BN-(7-14), were selected as carriers for radicals doxorubicin (DOX) and 2-pyrrolino-DOX to create hybrid cytotoxic analogs. All these compounds had a reduced peptide bond (CH2-NH or CH2-N) between positions 13 (Phe or Leu) and 14 (Phe, Leu, or Tac) (Tac = thiazolidine-4-carboxylic acid). Three pseudononapeptide carriers contained N-terminal D-Phe or D-Tpi at position 6 (Tpi = 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid). Two pseudooctapeptides had Gln7 at the N terminus. The conjugation of N-(9-fluorenylmethoxycarbonyl) doxorubicin (N-Fmoc-DOX)-14-O-hemiglutarate to the peptide carriers at the N terminus resulted in cytotoxic hybrids of BN-like peptides containing DOX. These hybrids could then be converted to analogs with 2-pyrrolino-DOX by a reaction with 4-iodobutyraldehyde. The ability of the carriers and the conjugates to inhibit the binding of 125I-labeled [Tyr4]BN to receptors for BN/gastrin releasing peptide (GRP) on Swiss 3T3 cells was determined. Cytotoxic conjugates of pseudooctapeptide carrier analogs displayed the highest binding affinity (KD approximately 1 nM). The cytotoxic BN analogs and their corresponding cytotoxic radicals exerted similar inhibitory effects on the in vitro growth of CFPAC-1 human pancreatic cancer, DMS-53 human lung cancer, PC-3 human prostate cancer, and MKN-45 human gastric cancer cell lines that have receptors for BN/GRP. In DMS-53 cells, the activity of 2-pyrrolino-DOX and its conjugates was approximately 2500 times higher than that of DOX and its hybrids. These highly potent cytotoxic analogs of BN have been designed as targeted anti-tumor agents for the treatment of various cancers that possess receptors for BN/GRP." @default.
• W1990032829 created "2016-06-24" @default.
• W1990032829 creator A5008707617 @default.
• W1990032829 creator A5013036085 @default.
• W1990032829 creator A5020268469 @default.
• W1990032829 creator A5056545203 @default.
• W1990032829 creator A5063861158 @default.
• W1990032829 creator A5068564667 @default.
• W1990032829 date "1997-01-21" @default.
• W1990032829 modified "2023-10-18" @default.
• W1990032829 title "Design, synthesis, and <i>in vitro</i> evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin" @default.
• W1990032829 cites W1537449868 @default.
• W1990032829 cites W1542038088 @default.
• W1990032829 cites W1562273048 @default.
• W1990032829 cites W1602529110 @default.
• W1990032829 cites W1769136676 @default.
• W1990032829 cites W1770260937 @default.
• W1990032829 cites W1850971940 @default.
• W1990032829 cites W1911837565 @default.
• W1990032829 cites W1983792141 @default.
• W1990032829 cites W1985755163 @default.
• W1990032829 cites W1989923573 @default.
• W1990032829 cites W1993491606 @default.
• W1990032829 cites W1994843266 @default.
• W1990032829 cites W1995084608 @default.
• W1990032829 cites W2017768512 @default.
• W1990032829 cites W2022705190 @default.
• W1990032829 cites W2028546559 @default.
• W1990032829 cites W2028576334 @default.
• W1990032829 cites W2030847748 @default.
• W1990032829 cites W2031956553 @default.
• W1990032829 cites W2041298584 @default.
• W1990032829 cites W2041662396 @default.
• W1990032829 cites W2044379086 @default.
• W1990032829 cites W2049887725 @default.
• W1990032829 cites W2056528570 @default.
• W1990032829 cites W2064025710 @default.
• W1990032829 cites W2078697485 @default.
• W1990032829 cites W2082819284 @default.
• W1990032829 cites W2083400626 @default.
• W1990032829 cites W2088080090 @default.
• W1990032829 cites W2090130076 @default.
• W1990032829 cites W2101679711 @default.
• W1990032829 cites W2109152919 @default.
• W1990032829 cites W2114082871 @default.
• W1990032829 cites W2147982205 @default.
• W1990032829 cites W2148735863 @default.
• W1990032829 cites W3144822602 @default.
• W1990032829 cites W375444644 @default.
• W1990032829 cites W74695622 @default.
• W1990032829 doi "https://doi.org/10.1073/pnas.94.2.652" @default.
• W1990032829 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/19568" @default.
• W1990032829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9012839" @default.
• W1990032829 hasPublicationYear "1997" @default.
• W1990032829 type Work @default.
• W1990032829 sameAs 1990032829 @default.
• W1990032829 citedByCount "82" @default.
• W1990032829 countsByYear W19900328292012 @default.
• W1990032829 countsByYear W19900328292013 @default.
• W1990032829 countsByYear W19900328292015 @default.
• W1990032829 countsByYear W19900328292016 @default.
• W1990032829 countsByYear W19900328292018 @default.
• W1990032829 countsByYear W19900328292019 @default.
• W1990032829 countsByYear W19900328292023 @default.
• W1990032829 crossrefType "journal-article" @default.
• W1990032829 hasAuthorship W1990032829A5008707617 @default.
• W1990032829 hasAuthorship W1990032829A5013036085 @default.
• W1990032829 hasAuthorship W1990032829A5020268469 @default.
• W1990032829 hasAuthorship W1990032829A5056545203 @default.
• W1990032829 hasAuthorship W1990032829A5063861158 @default.
• W1990032829 hasAuthorship W1990032829A5068564667 @default.
• W1990032829 hasBestOaLocation W19900328291 @default.
• W1990032829 hasConcept C109316439 @default.
• W1990032829 hasConcept C118303440 @default.
• W1990032829 hasConcept C154317977 @default.
• W1990032829 hasConcept C170493617 @default.
• W1990032829 hasConcept C185592680 @default.
• W1990032829 hasConcept C202751555 @default.
• W1990032829 hasConcept C2776694085 @default.
• W1990032829 hasConcept C2776998989 @default.
• W1990032829 hasConcept C2778448772 @default.
• W1990032829 hasConcept C2779281246 @default.
• W1990032829 hasConcept C2781303535 @default.
• W1990032829 hasConcept C54355233 @default.
• W1990032829 hasConcept C55493867 @default.
• W1990032829 hasConcept C71240020 @default.
• W1990032829 hasConcept C86803240 @default.
• W1990032829 hasConceptScore W1990032829C109316439 @default.
• W1990032829 hasConceptScore W1990032829C118303440 @default.
• W1990032829 hasConceptScore W1990032829C154317977 @default.
• W1990032829 hasConceptScore W1990032829C170493617 @default.
• W1990032829 hasConceptScore W1990032829C185592680 @default.
• W1990032829 hasConceptScore W1990032829C202751555 @default.
• W1990032829 hasConceptScore W1990032829C2776694085 @default.
• W1990032829 hasConceptScore W1990032829C2776998989 @default.
• W1990032829 hasConceptScore W1990032829C2778448772 @default.
• W1990032829 hasConceptScore W1990032829C2779281246 @default.
• W1990032829 hasConceptScore W1990032829C2781303535 @default.

• next